Titan Pharmaceuticals Inc (TTNP) Directors and Executive Officers

Officers & Directors

David Natan
Director

Dato Seow Gim Shen
Chairman of the Board

David E. Lazar
Chief Executive Officer

Brynner Chiam
Director

Katherine Beebe DeVarney, Ph.D.
President, Chief Operating Officer and Director

Avraham Ben-Tzvi, Adv.
Director

Matthew C. McMurdo, Esq.
Director

Eric Greenberg
Director

Brian E. Crowley
Vice President, Finance ,

Titan Pharmaceuticals Inc currently has 4 employees.

News about Titan Pharmaceuticals Inc Key Personnel

Titan Pharmaceuticals Regains NASDAQ Compliance and Works Towards Enhanced Financial Performance

Titan Pharmaceuticals Regains Compliance With NASDAQ Listing Criteria and Works Toward Improved ROI
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) has recently announced that it has successfully regained compliance with the minimum $1.00 bid price requirement, marking a positive development for the company. In a letter dated January 24, 2024, The Nasdaq Stock Market LLC confirmed that Titan meets all applicable criteria for continued listing on The Nasdaq Capital Market. As a result, the listing matter has been closed, relieving any concerns about potential delisting.
This news comes after the company faced financial challenges, recording a cumulative net loss of $-6 million during the 12-month period e...